Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Nov. 7, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 7, 2013

Agenus, Bayer, Celgene, Galderma, Genentech, NovaBay, Omeros, Regeneron, Roche

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Omeros TMA treatment well tolerated . . . read more

Phase II
Agenus posts good herpes vax results . . . read more

NovaBay impetigo treatment misses endpoint . . . read more

Phase III
Celgene to present Revlimid data at ASH . . . read more

Gazyva wallops Rituxan in CLL trial . . . read more

Filings
Bayer files for DME indication for Eylea . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics